Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  152 results for ""Neprilysin""

Your Filters

Geographic : china
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A novel variant of biallelic MME gene associated with autosomal recessive late-onset distal hereditary motor neuropathy in Chinese families.

  • Authors : Zhang B; Department of Neurology, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, 100034, China.; Gang Q

Subjects: Hereditary Sensory and Motor Neuropathy*/Hereditary Sensory and Motor Neuropathy*/Hereditary Sensory and Motor Neuropathy*/genetics ; Neprilysin*/Neprilysin*/Neprilysin*/genetics; Adult

  • Source: BMC medical genomics [BMC Med Genomics] 2024 Sep 04; Vol. 17 (1), pp. 223. Date of Electronic Publication: 2024 Sep 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101319628 Publication Model: Electronic Cited Medium: Internet ISSN: 1755-8794

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of the Efficacy and Safety of Sacubitril/Valsartan and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients With Reduced Ejection Fraction Combined With Moderate-to-Severe Chronic Kidney Disease.

  • Authors : Zhang Z; Department of Pharmacy, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.; Chen S

Subjects: Aminobutyrates*/Aminobutyrates*/Aminobutyrates*/adverse effects ; Aminobutyrates*/Aminobutyrates*/Aminobutyrates*/therapeutic use ; Valsartan*/Valsartan*/Valsartan*/therapeutic use

  • Source: Journal of cardiovascular pharmacology and therapeutics [J Cardiovasc Pharmacol Ther] 2024 Jan-Dec; Vol. 29, pp. 10742484241265337. Date of Electronic Publication: 2024 Jul 21.Publisher: Sage Publications Country of Publication: United States NLM ID: 9602617 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A randomized, double-blind, placebo-controlled, single, and multiple dose-escalation Phase I clinical trial to investigate the safety, pharmacokinetic, and pharmacodynamic profiles of oral S086, a novel angiotensin receptor-neprilysin inhibitor, in healthy Chinese volunteers.

  • Authors : Hu Y; Department of Phase I Clinical Trial Unit, First Hospital of Jilin University, Changchun, Jilin, China.; Zhang H

Subjects: Neprilysin* ; Receptors, Angiotensin*; Administration, Oral

  • Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2022 Sep; Vol. 31 (9), pp. 977-985. Date of Electronic Publication: 2021 Nov 08.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Chinese expert consensus on clinical application of angiotension-neprilysin inhibitor in patients with heart failure].

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Neprilysin*; Aminobutyrates

  • Source: Zhonghua xin xue guan bing za zhi [Zhonghua Xin Xue Guan Bing Za Zhi] 2022 Jul 24; Vol. 50 (7), pp. 662-670.Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7910682 Publication Model: Print Cited Medium: Print

Record details

Read More Add to Saved list
×
Academic Journal

Activating AhR alleviates cognitive deficits of Alzheimer's disease model mice by upregulating endogenous Aβ catabolic enzyme Neprilysin.

  • Authors : Qian C; Sir Run run Hospital, Nanjing Medical University, Nanjing, China.; Yang C

Subjects: Cognitive Dysfunction/Cognitive Dysfunction/Cognitive Dysfunction/*metabolism ; Neprilysin/Neprilysin/Neprilysin/*metabolism ; Receptors, Aryl Hydrocarbon/Receptors, Aryl Hydrocarbon/Receptors, Aryl Hydrocarbon/*metabolism

  • Source: Theranostics [Theranostics] 2021 Aug 11; Vol. 11 (18), pp. 8797-8812. Date of Electronic Publication: 2021 Aug 11 (Print Publication: 2021).Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

A CD10-OGP Membrane Peptolytic Signaling Axis in Fibroblasts Regulates Lipid Metabolism of Cancer Stem Cells via SCD1.

  • Authors : Yu S; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.; Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*metabolism ; Cancer-Associated Fibroblasts/Cancer-Associated Fibroblasts/Cancer-Associated Fibroblasts/*metabolism ; Histones/Histones/Histones/*metabolism

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2021 Oct; Vol. 8 (19), pp. e2101848. Date of Electronic Publication: 2021 Aug 07.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

Read More Add to Saved list
×
Academic Journal

Effects of Angiotensin Receptor Neprilysin Inhibitors on Inducibility of Ventricular Arrhythmias in Rats with Ischemic Cardiomyopathy.

  • Authors : Huo JY; Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University.; Jiang WY

Subjects: Connexin 43/Connexin 43/Connexin 43/*metabolism ; Myocardial Infarction/Myocardial Infarction/Myocardial Infarction/*drug therapy ; Neprilysin/Neprilysin/Neprilysin/*pharmacology

  • Source: International heart journal [Int Heart J] 2019 Sep 27; Vol. 60 (5), pp. 1168-1175. Date of Electronic Publication: 2019 Sep 04.Publisher: International Heart Journal Association Country of Publication: Japan NLM ID: 101244240 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40.

  • Authors : Zhao M; Laboratory of Cardiovascular Diseases, Regenerative Medicine Research Center, West China Hospital.; Xin Y

Subjects: Angiotensin Receptor Antagonists*/Angiotensin Receptor Antagonists*/Angiotensin Receptor Antagonists*/administration & dosage ; Angiotensin Receptor Antagonists*/Angiotensin Receptor Antagonists*/Angiotensin Receptor Antagonists*/adverse effects ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

  • Source: Medicine [Medicine (Baltimore)] 2019 Sep; Vol. 98 (39), pp. e17296.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Mutation screening and association study of the neprilysin gene in sporadic Alzheimer's disease in Chinese persons.

  • Authors : Shi J; Department of Medical Genetics, West China Hospital, Sichuan University, Chengdu, 610041, China.; Zhang S

Subjects: Mutation*; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*epidemiology ; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*genetics

  • Source: The journals of gerontology. Series A, Biological sciences and medical sciences [J Gerontol A Biol Sci Med Sci] 2005 Mar; Vol. 60 (3), pp. 301-6.Publisher: published on behalf of the Gerontological Society of America by Oxford University Press Country of Publication: United States NLM ID: 9502837

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study.

  • Authors : Kario K; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, 3311-1, Yakushiji, Shimotsuke, Tochigi 329-0498, Japan. .; Sun N

Subjects: Asian People*; Aminobutyrates/Aminobutyrates/Aminobutyrates/*therapeutic use ; Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/*therapeutic use

  • Source: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2014 Apr; Vol. 63 (4), pp. 698-705. Date of Electronic Publication: 2014 Jan 20.Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  152 results for ""Neprilysin""